T1	Participants 103 197	patients with primary Raynaud's phenomenon in South Korea; Korean Raynaud study (KOARA study).
T2	Participants 440 514	nifedipine SR group (Group N) or the Ginkgo biloba extract group (Group G)
T3	Participants 716 761	Ninety-three subjects were randomly assigned.
T4	Participants 1081 1097	Korean patients.
T5	Participants 1137 1149	RP patients.
